700138P

7-dehydrodesmosterol

powder

• 동의어(들): Cholesta-5,7,24-trien-3β-ol
• 실험식(Hill 표기법): C₂₇H₄₂O
• CAS Number: 1715-86-2
• Molecular Weight: 382.62
• MDL number: MFCD28359052
• UNSPSC 코드: 12352211
• NACRES: NA.25

속성

• 양식: powder
• 포장: pkg of 1 × 1 mg (700138P-1mg)
• 제조업체/상표: Avanti Research^™ - A Croda Brand 700138P
• 배송 상태: dry ice
• 저장 온도: −70°C
• SMILES string: O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@@H](CC[C@@H]4[C@@H](CCC=C(C)C)C)C3=CC=C2C1)C)C
• InChI: 1S/C27H42O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h7,9-10,19,21,23-25,28H,6,8,11-17H2,1-5H3/t19-,21+,23-,24+,25+,26+,27-/m1/s1
• InChI key: RUSSPKPUXDSHNC-DDPQNLDTSA-N

설명

일반 설명

7-dehydrodesmosterol (7-DHD) is synthesized via the Bloch pathway. 7-DHD serves as a desmosterol synthesis precursor and the enzyme 7-dehydrocholesterol reductase (DHCR7) catalyzes this step.

애플리케이션

7-dehydrodesmosterol has been used as an internal oxysterol standard in ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS).

생화학적/생리학적 작용

7-dehydrodesmosterol (7-DHD) levels are higher during fetal development and increases with aging. Elevated levels of 7-DHD is associated with Smith-Lemli-Opitz syndrome mouse model. Reduced levels of 7-DHD is observed in shiverer and quaking disorder.

포장

5 mL Amber Glass Screw Cap Vial (700138P-1mg)

법적 정보

Avanti Research is a trademark of Avanti Polar Lipids, LLC

안전성 정보

• Storage Class Code: 11 - Combustible Solids